Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 12, 2014, Pages 2034-2037

  Fontana, P ^a   Poncet, A ^a   Lindhoff Last, E ^b   de Moerloose, P ^a   Devreese, K M ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anticardiolipin antibody; Antiphospholipid antibodies; Antiphospholipid antibody syndrome; Beta 2 Glycoprotein I; Chemiluminescence

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD BANK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEMOSTASIS TESTING SYSTEM; HUMAN; LABORATORY; MALE; NORMAL HUMAN; THROMBOSIS; ALGORITHM; ANTIPHOSPHOLIPID SYNDROME; AUTOMATION; BLOOD; BLOOD DONOR; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; IMMUNOLOGY; LUMINESCENCE; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS;

ADULT; ALGORITHMS; ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOMATION; BETA 2-GLYCOPROTEIN I; BLOOD DONORS; CARDIOLIPINS; CLINICAL LABORATORY TECHNIQUES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LUMINESCENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 84916619949     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12732     Document Type: Article

References (17)

1. Devreese KM. Standardization of antiphospholipid antibody assays. Where do we stand? Lupus 2012; 21: 718-21.
2. Devreese KM, Pierangeli SS, de Laat B, Tripodi A, Atsumi T, Ortel TL. Testing for Antiphospholipid antibodies with Solid Phase Assays: recommendations from the Subcommittee on Lupus Anticoagulant/Phospholipid-Dependent Antibodies. J Thromb Haemost 2014; 36: 352-63.
3. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.
4. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-8.
5. Urbanus RT, de Groot PG. Antiphospholipid antibodies-we are not quite there yet. Blood Rev 2011; 25: 97-106.
6. Ruffatti A, Olivieri S, Tonello M, Bortolati M, Bison E, Salvan E, Facchinetti M, Pengo V. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost 2008; 6: 1693-6.
7. Forastiero R, Papalardo E, Watkins M, Nguyen H, Quirbach C, Jaskal K, Kast M, Teodorescu M, Lakos G, Binder W, Shums Z, Nelson V, Norman G, Puig J, Cox A, Vandam W, Hardy J, Pierangeli S. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2014; 428: 99-105.
8. Pierangeli SS, Favaloro EJ, Lakos G, Meroni PL, Tincani A, Wong RC, Harris EN. Standards and reference materials for the anticardiolipin and anti-beta2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2012; 413: 358-60.
9. de Moerloose P, Reber G, Musial J, Arnout J. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost 2010; 8: 1540-6.
10. van Hoecke F, Persijn L, Decavele AS, Devreese K. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2012; 6: 630-40.
11. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
12. Lakos G, Favaloro EJ, Harris EN, Meroni PL, Tincani A, Wong RC, Pierangeli SS. International consensus guidelines on anticardiolipin and anti-beta2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum 2012; 64: 1-10.
13. Wong RC. Consensus guidelines for anticardiolipin antibody testing. Thromb Res 2004; 114: 559-71.
14. Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
15. Devreese KM, van Hoecke F. Anticardiolipin and anti-beta2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thromb Res 2011; 128: 598-600.
16. Box GEP, Cox DR. An analysis of transformations. J Roy Stat Soc 1964; B26: 211-52.
17. Oehlert GW. A Note on the Delta Method. Am Stat 1992; 46: 27-9.